Pretreatment with serotonin 5-HT(3) receptor antagonists produces no observable blockade of long-term motor sensitization to cocaine in rats

Serotonin 5-HT(3) receptor antagonists are proposed to serve as potential anti-addictive and anti-psychotic therapies. The present study re-examined the hypothesis that the activation of 5-HT(3) receptors is required for the development of long-term motor sensitization to repeated cocaine (COC). Rat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Psychopharmacology 2003-02, Vol.165 (4), p.329
Hauptverfasser: Szumlinski, Karen K, Frys, Kelly A, Kalivas, Peter W
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 4
container_start_page 329
container_title Psychopharmacology
container_volume 165
creator Szumlinski, Karen K
Frys, Kelly A
Kalivas, Peter W
description Serotonin 5-HT(3) receptor antagonists are proposed to serve as potential anti-addictive and anti-psychotic therapies. The present study re-examined the hypothesis that the activation of 5-HT(3) receptors is required for the development of long-term motor sensitization to repeated cocaine (COC). Rats were pretreated with vehicle (VEH) or one of three 5-HT(3) receptor antagonists, MDL 72222, Y-25130 or ondansetron, 30 min prior to seven daily COC or saline (SAL) injections. Three weeks later, animals were challenged with COC in a test for sensitization. For comparison, the effects of pretreatment with the dopamine (DA) receptor antagonist fluphenazine and a combination of fluphenazine and Y-25130 were assessed. Pretreatment with ondansetron, Y-25130, fluphenazine and their combination significantly attenuated COC-induced behaviors during repeated treatment but not on the test for sensitization. MDL 72222 pretreatment enhanced motor sensitization on the test day. In repeated SAL rats, pretreatment with ondansetron, Y-25130 and fluphenazine+Y-25130 enhanced COC-induced rearing on the test for sensitization. These data indicate the effects of 5-HT(3) receptor antagonists on both acute COC-induced motor behavior and COC-induced motor sensitization are compound-selective. As none of the 5-HT(3) receptor antagonists attenuated the magnitude of the sensitized motor response to COC in the long term, these data also indicate that like DA receptor activation, 5-HT(3) receptor activation is necessary for the full expression of acute COC-induced motor hyperactivity, but it is not required for the development of long-term motor sensitization.
format Article
fullrecord <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_12451437</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>12451437</sourcerecordid><originalsourceid>FETCH-LOGICAL-p547-536728a9a87a91708f7692ec8ff728f1a77ebd669428374ac8e922805dc203983</originalsourceid><addsrcrecordid>eNo1UMFKxDAUzEFx19VfkHfUQ6FN0iY9yqLuwoIeel9e09c12iYlySr6DX60FXUuAzPMDMwJW-a5EJkoSr1g5zG-5DOklmdsUXBZFlKoJft6CpQCYRrJJXi36RkiBZ-8sw7KbNNcixsIZGhKPgC6hIfZiinCFHx3NBTBefDtHHrDdiBoB29esSPwPQzeHbJEYYTR_8QjuWiT_cRkvYPkwXiD1hHMWwFTvGCnPQ6RLv94xZr7u2a9yXaPD9v17S6bSqmyUlSKa6xRK6wLleteVTUno_t-1vsClaK2q6paci2URKOp5lznZWd4LmotVuzqt3Y6tiN1-ynYEcPH_v8V8Q1o1F9Z</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Pretreatment with serotonin 5-HT(3) receptor antagonists produces no observable blockade of long-term motor sensitization to cocaine in rats</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Szumlinski, Karen K ; Frys, Kelly A ; Kalivas, Peter W</creator><creatorcontrib>Szumlinski, Karen K ; Frys, Kelly A ; Kalivas, Peter W</creatorcontrib><description>Serotonin 5-HT(3) receptor antagonists are proposed to serve as potential anti-addictive and anti-psychotic therapies. The present study re-examined the hypothesis that the activation of 5-HT(3) receptors is required for the development of long-term motor sensitization to repeated cocaine (COC). Rats were pretreated with vehicle (VEH) or one of three 5-HT(3) receptor antagonists, MDL 72222, Y-25130 or ondansetron, 30 min prior to seven daily COC or saline (SAL) injections. Three weeks later, animals were challenged with COC in a test for sensitization. For comparison, the effects of pretreatment with the dopamine (DA) receptor antagonist fluphenazine and a combination of fluphenazine and Y-25130 were assessed. Pretreatment with ondansetron, Y-25130, fluphenazine and their combination significantly attenuated COC-induced behaviors during repeated treatment but not on the test for sensitization. MDL 72222 pretreatment enhanced motor sensitization on the test day. In repeated SAL rats, pretreatment with ondansetron, Y-25130 and fluphenazine+Y-25130 enhanced COC-induced rearing on the test for sensitization. These data indicate the effects of 5-HT(3) receptor antagonists on both acute COC-induced motor behavior and COC-induced motor sensitization are compound-selective. As none of the 5-HT(3) receptor antagonists attenuated the magnitude of the sensitized motor response to COC in the long term, these data also indicate that like DA receptor activation, 5-HT(3) receptor activation is necessary for the full expression of acute COC-induced motor hyperactivity, but it is not required for the development of long-term motor sensitization.</description><identifier>ISSN: 0033-3158</identifier><identifier>PMID: 12451437</identifier><language>eng</language><publisher>Germany</publisher><subject>Anesthetics, Local - pharmacology ; Animals ; Bridged Bicyclo Compounds, Heterocyclic - pharmacology ; Cocaine - pharmacology ; Dopamine Antagonists - pharmacology ; Dose-Response Relationship, Drug ; Drug Administration Schedule - veterinary ; Drug Interactions ; Fluphenazine - pharmacology ; Injections ; Male ; Motor Activity - drug effects ; Motor Activity - physiology ; Ondansetron - pharmacology ; Oxazines - pharmacology ; Rats ; Rats, Sprague-Dawley ; Receptors, Serotonin - drug effects ; Receptors, Serotonin - metabolism ; Receptors, Serotonin, 5-HT3 ; Serotonin Antagonists - pharmacology ; Tropanes - pharmacology</subject><ispartof>Psychopharmacology, 2003-02, Vol.165 (4), p.329</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12451437$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Szumlinski, Karen K</creatorcontrib><creatorcontrib>Frys, Kelly A</creatorcontrib><creatorcontrib>Kalivas, Peter W</creatorcontrib><title>Pretreatment with serotonin 5-HT(3) receptor antagonists produces no observable blockade of long-term motor sensitization to cocaine in rats</title><title>Psychopharmacology</title><addtitle>Psychopharmacology (Berl)</addtitle><description>Serotonin 5-HT(3) receptor antagonists are proposed to serve as potential anti-addictive and anti-psychotic therapies. The present study re-examined the hypothesis that the activation of 5-HT(3) receptors is required for the development of long-term motor sensitization to repeated cocaine (COC). Rats were pretreated with vehicle (VEH) or one of three 5-HT(3) receptor antagonists, MDL 72222, Y-25130 or ondansetron, 30 min prior to seven daily COC or saline (SAL) injections. Three weeks later, animals were challenged with COC in a test for sensitization. For comparison, the effects of pretreatment with the dopamine (DA) receptor antagonist fluphenazine and a combination of fluphenazine and Y-25130 were assessed. Pretreatment with ondansetron, Y-25130, fluphenazine and their combination significantly attenuated COC-induced behaviors during repeated treatment but not on the test for sensitization. MDL 72222 pretreatment enhanced motor sensitization on the test day. In repeated SAL rats, pretreatment with ondansetron, Y-25130 and fluphenazine+Y-25130 enhanced COC-induced rearing on the test for sensitization. These data indicate the effects of 5-HT(3) receptor antagonists on both acute COC-induced motor behavior and COC-induced motor sensitization are compound-selective. As none of the 5-HT(3) receptor antagonists attenuated the magnitude of the sensitized motor response to COC in the long term, these data also indicate that like DA receptor activation, 5-HT(3) receptor activation is necessary for the full expression of acute COC-induced motor hyperactivity, but it is not required for the development of long-term motor sensitization.</description><subject>Anesthetics, Local - pharmacology</subject><subject>Animals</subject><subject>Bridged Bicyclo Compounds, Heterocyclic - pharmacology</subject><subject>Cocaine - pharmacology</subject><subject>Dopamine Antagonists - pharmacology</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug Administration Schedule - veterinary</subject><subject>Drug Interactions</subject><subject>Fluphenazine - pharmacology</subject><subject>Injections</subject><subject>Male</subject><subject>Motor Activity - drug effects</subject><subject>Motor Activity - physiology</subject><subject>Ondansetron - pharmacology</subject><subject>Oxazines - pharmacology</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Receptors, Serotonin - drug effects</subject><subject>Receptors, Serotonin - metabolism</subject><subject>Receptors, Serotonin, 5-HT3</subject><subject>Serotonin Antagonists - pharmacology</subject><subject>Tropanes - pharmacology</subject><issn>0033-3158</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1UMFKxDAUzEFx19VfkHfUQ6FN0iY9yqLuwoIeel9e09c12iYlySr6DX60FXUuAzPMDMwJW-a5EJkoSr1g5zG-5DOklmdsUXBZFlKoJft6CpQCYRrJJXi36RkiBZ-8sw7KbNNcixsIZGhKPgC6hIfZiinCFHx3NBTBefDtHHrDdiBoB29esSPwPQzeHbJEYYTR_8QjuWiT_cRkvYPkwXiD1hHMWwFTvGCnPQ6RLv94xZr7u2a9yXaPD9v17S6bSqmyUlSKa6xRK6wLleteVTUno_t-1vsClaK2q6paci2URKOp5lznZWd4LmotVuzqt3Y6tiN1-ynYEcPH_v8V8Q1o1F9Z</recordid><startdate>200302</startdate><enddate>200302</enddate><creator>Szumlinski, Karen K</creator><creator>Frys, Kelly A</creator><creator>Kalivas, Peter W</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>200302</creationdate><title>Pretreatment with serotonin 5-HT(3) receptor antagonists produces no observable blockade of long-term motor sensitization to cocaine in rats</title><author>Szumlinski, Karen K ; Frys, Kelly A ; Kalivas, Peter W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p547-536728a9a87a91708f7692ec8ff728f1a77ebd669428374ac8e922805dc203983</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Anesthetics, Local - pharmacology</topic><topic>Animals</topic><topic>Bridged Bicyclo Compounds, Heterocyclic - pharmacology</topic><topic>Cocaine - pharmacology</topic><topic>Dopamine Antagonists - pharmacology</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug Administration Schedule - veterinary</topic><topic>Drug Interactions</topic><topic>Fluphenazine - pharmacology</topic><topic>Injections</topic><topic>Male</topic><topic>Motor Activity - drug effects</topic><topic>Motor Activity - physiology</topic><topic>Ondansetron - pharmacology</topic><topic>Oxazines - pharmacology</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Receptors, Serotonin - drug effects</topic><topic>Receptors, Serotonin - metabolism</topic><topic>Receptors, Serotonin, 5-HT3</topic><topic>Serotonin Antagonists - pharmacology</topic><topic>Tropanes - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Szumlinski, Karen K</creatorcontrib><creatorcontrib>Frys, Kelly A</creatorcontrib><creatorcontrib>Kalivas, Peter W</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Psychopharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Szumlinski, Karen K</au><au>Frys, Kelly A</au><au>Kalivas, Peter W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pretreatment with serotonin 5-HT(3) receptor antagonists produces no observable blockade of long-term motor sensitization to cocaine in rats</atitle><jtitle>Psychopharmacology</jtitle><addtitle>Psychopharmacology (Berl)</addtitle><date>2003-02</date><risdate>2003</risdate><volume>165</volume><issue>4</issue><spage>329</spage><pages>329-</pages><issn>0033-3158</issn><abstract>Serotonin 5-HT(3) receptor antagonists are proposed to serve as potential anti-addictive and anti-psychotic therapies. The present study re-examined the hypothesis that the activation of 5-HT(3) receptors is required for the development of long-term motor sensitization to repeated cocaine (COC). Rats were pretreated with vehicle (VEH) or one of three 5-HT(3) receptor antagonists, MDL 72222, Y-25130 or ondansetron, 30 min prior to seven daily COC or saline (SAL) injections. Three weeks later, animals were challenged with COC in a test for sensitization. For comparison, the effects of pretreatment with the dopamine (DA) receptor antagonist fluphenazine and a combination of fluphenazine and Y-25130 were assessed. Pretreatment with ondansetron, Y-25130, fluphenazine and their combination significantly attenuated COC-induced behaviors during repeated treatment but not on the test for sensitization. MDL 72222 pretreatment enhanced motor sensitization on the test day. In repeated SAL rats, pretreatment with ondansetron, Y-25130 and fluphenazine+Y-25130 enhanced COC-induced rearing on the test for sensitization. These data indicate the effects of 5-HT(3) receptor antagonists on both acute COC-induced motor behavior and COC-induced motor sensitization are compound-selective. As none of the 5-HT(3) receptor antagonists attenuated the magnitude of the sensitized motor response to COC in the long term, these data also indicate that like DA receptor activation, 5-HT(3) receptor activation is necessary for the full expression of acute COC-induced motor hyperactivity, but it is not required for the development of long-term motor sensitization.</abstract><cop>Germany</cop><pmid>12451437</pmid></addata></record>
fulltext fulltext
identifier ISSN: 0033-3158
ispartof Psychopharmacology, 2003-02, Vol.165 (4), p.329
issn 0033-3158
language eng
recordid cdi_pubmed_primary_12451437
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Anesthetics, Local - pharmacology
Animals
Bridged Bicyclo Compounds, Heterocyclic - pharmacology
Cocaine - pharmacology
Dopamine Antagonists - pharmacology
Dose-Response Relationship, Drug
Drug Administration Schedule - veterinary
Drug Interactions
Fluphenazine - pharmacology
Injections
Male
Motor Activity - drug effects
Motor Activity - physiology
Ondansetron - pharmacology
Oxazines - pharmacology
Rats
Rats, Sprague-Dawley
Receptors, Serotonin - drug effects
Receptors, Serotonin - metabolism
Receptors, Serotonin, 5-HT3
Serotonin Antagonists - pharmacology
Tropanes - pharmacology
title Pretreatment with serotonin 5-HT(3) receptor antagonists produces no observable blockade of long-term motor sensitization to cocaine in rats
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T17%3A26%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pretreatment%20with%20serotonin%205-HT(3)%20receptor%20antagonists%20produces%20no%20observable%20blockade%20of%20long-term%20motor%20sensitization%20to%20cocaine%20in%20rats&rft.jtitle=Psychopharmacology&rft.au=Szumlinski,%20Karen%20K&rft.date=2003-02&rft.volume=165&rft.issue=4&rft.spage=329&rft.pages=329-&rft.issn=0033-3158&rft_id=info:doi/&rft_dat=%3Cpubmed%3E12451437%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/12451437&rfr_iscdi=true